# Juvista (Avotermin) in the Prevention or Improvement of Scar Appearance Following Scar Revision Surgery.

> **NCT00432211** · PHASE2 · UNKNOWN · sponsor: **Renovo** · enrollment: 60 (estimated)

## Conditions studied

- Cicatrix

## Interventions

- **DRUG:** Avotermin

## Key facts

- **NCT ID:** NCT00432211
- **Lead sponsor:** Renovo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-05
- **Primary completion:** 2008-07
- **Final completion:** 2012-09
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2009-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00432211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00432211, "Juvista (Avotermin) in the Prevention or Improvement of Scar Appearance Following Scar Revision Surgery.". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00432211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*